You are currently viewing a new version of our website. To view the old version click .

Chronic Kidney Disease and Its Complications: Mechanisms and Treatments

This special issue belongs to the section “Nephrology & Urology“.

Special Issue Information

Dear Colleagues,

Chronic kidney disease (CKD) affects approximately 10–14% of the global population. Kidney fibrosis, characterized by excessive extracellular matrix (ECM) deposition leading to tissue scarring, is a hallmark and common manifestation in all types of progressive CKD; however, there are currently no antifibrotic therapies used to treat CKD. Kidney fibrosis can be identified based on morphological features such as tubule atrophy, interstitial chronic inflammation and fibrogenesis, glomerulosclerosis, and vascular rarefaction. Although it takes a long time to develop effective drugs based on newly discovered mechanisms, the increasing number of treatments on the market, including RAS blockage, SGLT2 inhibitors, vasopressin receptor 2 antagonist, and non-steroidal anti-mineralocorticoid, can delay the progression of CKD. Furthermore, a better understanding of kidney fibrosis will also aid the discovery of promising blood and urinary biomarkers related to tubulointerstitial injury.

Dr. Liang Ma
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • chronic kidney disease
  • kidney fibrosis
  • myofibroblast activation
  • tubulointerstitial injury
  • fibrotic biomarker
  • antifibrotic therapy

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Published Papers

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
J. Clin. Med. - ISSN 2077-0383